Anthropic wants to develop its own drugs
Evolving story · 3 updatesAnthropic’s Claude Science LaunchTimeline →Anthropic unveiled Claude Science, an AI workbench for researchers, at an event this week. The tool integrates fragmented datasets and generates visuals to accelerate scientific discovery and healthcare development.
- Claude Science is an AI workbench designed to unify fragmented datasets and tools for researchers.
- The platform aims to accelerate scientific discovery and healthcare interventions, particularly in drug development.
- Anthropic claims multiple biotech and pharma customers are already using the tool.
- This marks Anthropic's expansion into specialized AI applications beyond general-purpose models.
At the 'AI for Science' event, Anthropic introduced Claude Science, a new AI workbench tailored for scientists. The platform consolidates fragmented tools and datasets into a single environment, enabling researchers to generate figures and visuals more efficiently. Anthropic emphasized the tool's potential to significantly speed up scientific discovery and healthcare interventions, highlighting its relevance in drug development.
The company, known for its advanced AI models and coding tools, also revealed that several biotech and pharmaceutical customers are already leveraging Claude. This move underscores Anthropic's expanding focus beyond general-purpose AI applications into specialized domains like healthcare and scientific research. The announcement reflects a growing trend of AI companies targeting niche industries to drive real-world impact.
Provides a new AI-driven environment for scientific research and data integration.
Offers a potential competitive edge in drug discovery and healthcare innovation.
Highlights Anthropic's strategic pivot toward high-impact, specialized AI applications.
Demonstrates how AI can transform traditional scientific workflows.
- AI workbench
- A software environment that integrates tools, datasets, and workflows to streamline research and development processes.
AI ToolsYour agent ignored a failed tool call. Here's how to catch that in CI.
AI ToolsSame Cluster, 33 Points More Utilization: What Changed Was the Order
Classroom solution evolves into public resource for navigating AI tools - Iowa State University
Build OpenClaw agents that transact with Amazon Bedrock AgentCore payments - Amazon Web Services (AWS)
Mining the National Archives: New Exhibition Sparks Personalized Discovery with AI - American Alliance of Museums
Cloud-Based Artificial Intelligence Classification of Common Intracranial Tumors on Magnetic Resonance Imaging - Cureus
A new AI model published in Cureus can classify common brain tumors from MRI scans using cloud computing.
Executives put the spotlight on AI’s reliability issue - CIO Dive
CIOs are prioritizing AI reliability as a critical risk, with executives calling for stricter validation and governance frameworks to address operational failures.
State and Local Security Leaders Share How They Handle Vendor AI Use - StateTech Magazine
State and local security leaders discuss how they oversee AI use by vendors to mitigate risks and ensure compliance.
Billionaire Ray Dalio Says Today's Artificial Intelligence (AI) Market Echoes 1929 and 2000. History Says Investors Should Watch Valuations Closely. - Yahoo Finance
Billionaire investor Ray Dalio compares today's AI market valuations to the periods before the 1929 stock market crash and the dot-com bubble burst.
OUTPUT v. INPUT- Copyright Ownership Challenges in the Era of Artificial Intelligence - The National Law Review
The National Law Review examines the complex legal landscape of copyright ownership, focusing on the distinction between AI-generated content (output) and the data used for training AI models (input). This analysis highlights the significant challenges current intellectual property laws face in the era of artificial intelligence.
Artificial Intelligence helps Munson health care provider focus more on patients, less on screens - DVIDS
A Michigan healthcare provider is using AI to cut down on screen time for clinicians, allowing them to spend more time with patients.